Drugs / Measles and Mumps Combined Vaccine，Live(SIBP)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03133923 Comparator | May → Nov 2017 | mumps infectious disease | Institute of Medical Biology, Chinese Academy of Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Measles and Mumps Combined Vaccine，Live(SIBP) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03133923 ↗ |
| Known as | Measles and Mumps Combined Vaccine，Live | “Measles and Mumps Combined Vaccine，Live(SIBP)( positive control)” NCT03133923 ↗ |
| Modality | Vaccine | “Measles and Mumps Combined Vaccine，Live” NCT03133923 ↗ |